PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$8.87
Tradestie Score
65
Market Cap
$871.90M
Revenue Growth
0.9%
Analyst Upside
+142.4%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$29.12
|
$748.90M | - | 58 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.01
|
$726.21M | 16.3 | 50 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$26.72
|
$718.62M | - | 35 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$26.05
|
$715.25M | - | 62 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$142.04
|
$699.30M | - | 40 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.91
|
$688.47M | - | 38 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
ARVN
Arvinas, Inc
|
$9.37
|
$670.30M | 37.6 | 41 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$14.34
|
$665.30M | 17.3 | 34 | Compare |
More PHAT Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry